Genzyme Corporation v. Anika Therapeutics, Inc

Patent infringement. The plaintiff is a global biotechnology company with products and services focused on rare inherited disorders, kidney disease, orthopedics, cancer, transplant and immune disease. The defendants have infringed on the plaintiff’s treatment regimen for pain in osteoarthritis with their injectable product, Monovisc. Plaintiff seeks to enjoin the defendants from selling Monovisc.